XTX Topco Ltd Makes New Investment in Colgate-Palmolive Company (NYSE:CL)

Key Points

• XTX Topco Ltd has invested approximately $606,000 in Colgate-Palmolive Company by purchasing 6,467 shares during the first quarter.
• Colgate-Palmolive recently reported earnings of $0.92 EPS for the quarter, exceeding expectations, with revenues totaling $5.11 billion.
• The company's quarterly dividend of $0.52 will be paid on August 15th, representing a 2.5% dividend yield with a payout ratio of 58.43%.

XTX Topco Ltd acquired a new stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 6,467 shares of the company's stock, valued at approximately $606,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Northern Trust Corp lifted its position in shares of Colgate-Palmolive by 11.7% in the fourth quarter. Northern Trust Corp now owns 9,497,819 shares of the company's stock worth $863,447,000 after purchasing an additional 993,328 shares in the last quarter. Deutsche Bank AG lifted its position in shares of Colgate-Palmolive by 35.6% in the fourth quarter. Deutsche Bank AG now owns 6,922,994 shares of the company's stock worth $629,369,000 after purchasing an additional 1,816,865 shares in the last quarter. Ameriprise Financial Inc. lifted its position in shares of Colgate-Palmolive by 3.8% in the fourth quarter. Ameriprise Financial Inc. now owns 6,798,821 shares of the company's stock worth $617,359,000 after purchasing an additional 246,908 shares in the last quarter. Invesco Ltd. lifted its position in shares of Colgate-Palmolive by 2.7% in the fourth quarter. Invesco Ltd. now owns 6,537,918 shares of the company's stock worth $594,362,000 after purchasing an additional 169,140 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Colgate-Palmolive by 11.2% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 6,299,989 shares of the company's stock worth $572,732,000 after purchasing an additional 632,653 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Colgate-Palmolive Stock Down 0.0%

CL stock traded down $0.00 during midday trading on Friday, reaching $84.71. 4,133,894 shares of the company's stock traded hands, compared to its average volume of 4,850,591. The company has a market cap of $68.46 billion, a price-to-earnings ratio of 23.79, a P/E/G ratio of 4.41 and a beta of 0.35. The firm's fifty day moving average price is $88.76 and its 200-day moving average price is $90.13. The company has a quick ratio of 0.28, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. Colgate-Palmolive Company has a 52 week low of $82.40 and a 52 week high of $109.30.

Colgate-Palmolive (NYSE:CL - Get Free Report) last posted its earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. During the same quarter in the prior year, the business posted $0.91 EPS. The business's revenue was up 1.0% compared to the same quarter last year. As a group, sell-side analysts forecast that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 15th. Investors of record on Friday, July 18th will be issued a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend is Friday, July 18th. Colgate-Palmolive's payout ratio is 58.43%.

Analyst Ratings Changes

CL has been the topic of a number of research reports. Wall Street Zen lowered shares of Colgate-Palmolive from a "buy" rating to a "hold" rating in a research report on Wednesday, May 7th. Barclays upped their price target on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an "equal weight" rating in a research report on Tuesday, July 15th. Citigroup dropped their price objective on shares of Colgate-Palmolive from $108.00 to $105.00 and set a "buy" rating on the stock in a research report on Monday, August 4th. UBS Group dropped their price objective on shares of Colgate-Palmolive from $109.00 to $106.00 and set a "buy" rating on the stock in a research report on Thursday, July 17th. Finally, JPMorgan Chase & Co. dropped their price objective on shares of Colgate-Palmolive from $99.00 to $95.00 and set an "overweight" rating on the stock in a research report on Monday, August 4th. One analyst has rated the stock with a sell rating, five have given a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, Colgate-Palmolive has an average rating of "Hold" and a consensus price target of $98.92.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.